Thirteen compounds promoting oligodendrocyte progenitor cell differentiation and remyelination for treating multiple sclerosis: WO2010054307

Expert Opinion on Therapeutic Patents

Volumn 20, Issue 12, 2010, Pages 1767-1773

  Taupin, Philippe ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

CNS; MS; myelin; neural stem cells; neurological diseases; regeneration; therapy

Indexed keywords

AMIDE; AMINE; CENTRAL NERVOUS SYSTEM AGENTS; IMINE; NITRO DERIVATIVE; NITROSO DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL CULTURE; CELL DIFFERENTIATION; CEREBELLUM; CONTROLLED STUDY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG SCREENING; DRUG SYNTHESIS; EMBRYO; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PATENT; REMYELINIZATION; REVIEW; STEM CELL; ZEBRA FISH;

ANIMALS; CELL DIFFERENTIATION; HUMANS; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; PATENTS AS TOPIC; STEM CELLS;

EID: 78649290619     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.2010.528393     Document Type: Review

References (27)

1. Giuliani F, Yong VW. Immune-mediated neurodegeneration and neuroprotection in MS. Int MS J 2003;10:122-30
2. Yong VW. Prospects for neuroprotection in multiple sclerosis. Front Biosci 2004;9:864-72
3. Dhib-Jalbut S, Arnold DL, Cleveland DW, et al. Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases. J Neuroimmunol 2006;176:198-215
4. Glass CK, Saijo K, Winner B, et al. Mechanisms underlying inflammation in neurodegeneration. Cell 2010;140:918-34
5. Aharoni R, Arnon R. Linkage between immunomodulation, neuroprotection and neurogenesis. Drug News Perspect 2009;22:301-12
6. Aktas O, Kieseier B, Hartung HP. Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis. Trends Neurosci 2010;33:140-52
7. Mangas A, Covenas R, Geffard M. New drug therapies for multiple sclerosis. Curr Opin Neurol 2010;23:287-92
8. Saijo K, Crotti A, Glass CK. Nuclear receptors, inflammation, and neurodegenerative diseases. Adv Immunol 2010;106:21-59
9. Van der Walt A, Butzkueven H, Kolbe S, et al. Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade. Pharmacol Ther 2010;126:82-93
10. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992;255:1707-10
11. Reynolds BA, Tetzlaff W, Weiss S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci 1992;12:4565-74
12. Weiss S, Reynolds B. Novel growth factor-responsive progenitor cells which can be proliferated in vitro. WO1993001275; 1993
13. Yoshida M, Macklin WB. Oligodendrocyte development and myelination in GFP-transgenic zebrafish. J Neurosci Res 2005;81:1-8
14. Wu QZ, Yang Q, Cate HS, et al. MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model. J Magn Reson Imaging 2008;27:446-53
15. Taupin P. BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation. Brain Res Rev 2007;53:198-214
16. Weiss S, Reynolds BA, Hammang JP. Remyelination using neural stem cells. EP0664832B1; 2002
17. Yong VW, Giuliani F, Xue M, et al. Experimental models of neuroprotection relevant to multiple sclerosis. Neurology 2007;68:S32-7
18. De Santi L, Annunziata P, Sessa E, et al. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neurol Sci 2009;287:17-26
19. Palmer TD, Schwartz PH, Taupin P, et al. Cell culture. Progenitor cells from human brain after death. Nature 2001;411:42-3
20. Taupin P, Gage FH. Adult neurogenesis and neural stem cells of the central nervous system in mammals. J Neurosci Res 2002;69:745-9
21. Duan X, Kang E, Liu CY, et al. Development of neural stem cell in the adult brain. Curr Opin Neurobiol 2008;18:108-15
22. Taupin P. The therapeutic potential of adult neural stem cells. Curr Opin Mol Ther 2006;8:225-31
23. Taupin P. Nootropic agents stimulate neurogenesis. Expert Opin Ther Pat 2009;19:727-30
24. Taupin P. Fourteen compounds and their derivatives for the treatment of diseases and injuries characterized by reduced neurogenesis and neurodegeneration. Expert Opin Ther Pat 2009;19:541-7
25. Taupin P. Apigenin and related compounds stimulate adult neurogenesis. Expert Opin Ther Pat 2009;19:523-7
26. Taupin P. Adult neurogenesis and neural stem cells as a model for the discovery and development of novel drugs. Expert Opin Drug Discov 2010;5:921-25
27. Taupin P. Neurogenic drugs and compounds. Recent Pat CNS Drug Discov 2010;5:253-7